Holdings

Armistice Capital, LLC

As of Sep 30, 2026, Armistice Capital, LLC reported 298 positions worth US$2.95B. Largest: Supernus Pharmaceuticals, Inc., Agios Pharmaceuticals, Inc. and PTC Therapeutics, Inc. What it bought and sold, with each filing.

CompanySharesValue as reportedChangeAs of
Supernus Pharmaceuticals, Inc.2.55MUS$110M−98,201Sep 30, 2026
Agios Pharmaceuticals, Inc.2.58MUS$85.7M+178KSep 30, 2026
PTC Therapeutics, Inc.1.3MUS$84.1M+226KSep 30, 2026
Neurocrine Biosciences, Inc.565KUS$80.2M+29,413Sep 30, 2026
Cytokinetics, Incorporated1.18MUS$77.8M−21,150Sep 30, 2026
Travere Therapeutics, Inc.1.29MUS$75.9M−283KSep 30, 2026
Rigel Pharmaceuticals, Inc.1.54MUS$74M−136KSep 30, 2026
Incyte Corporation600KUS$72.8M−300KSep 30, 2026
Ironwood Pharmaceuticals, Inc.15MUS$59.5M+1.07MSep 30, 2026
Immunovant, Inc.1.74MUS$58.7M+2,169Sep 30, 2026